Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Depression linked to a higher stroke risk among heart attack survivors

The new findings, based on data from nearly 500,000 patients, were presented during ACC.22.

More than 6,000 IN.PACT Admiral Drug-Coated Balloons have been recalled, Medtronic announced Thursday.

Medtronic recalls more than 6,000 catheters due to potential damage, loss of sterility

The issue, identified during a routine inspection, appears to be related to a change in the manufacturing process. It has now been corrected, Medtronic said in a statement. 

Regularly eating avocados is associated with a reduced risk of cardiovascular disease, according to a new study.

Eating avocados lowers CVD risk

The new analysis, published in the Journal of the American Heart Association, included patient data from the last three decades. 

Examples of prosthetic heart valve thrombus formation on the valve leaflets. A new study shows better outcomes using tPA vs. surgery to remove the clots. Image from Mayo Clinic

Thrombolysis vs. surgery for prosthetic valve thrombosis

The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.

New-look imaging technique could change the way we see blood vessels

The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity. 

Thumbnail

DOACs may reduce the risk of dementia among AFib patients by 50%

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 

Interventional cardiology procedure in a cath lab at Beaumont Hospital.

PCI boosts survival for ischemic HF patients with moderate-to-severe mitral regurgitation

Mortality rates can be especially high for ischemic HF patients presenting with FMR and LVSD, but PCI may offer some relief. 

Evolocumab

Evolocumab limits adverse cardiovascular outcomes among PCI patients

Data from the FOURIER trial helped clinicians learn more about this popular PCSK9 inhibitor.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.